Free Trial
ETR:EVT

Evotec (EVT) Stock Price, News & Analysis

Evotec logo
€2.97 -0.16 (-5.06%)
As of 11/13/2026

About Evotec Stock (ETR:EVT)

Advanced

Key Stats

Today's Range
€2.97
▼
€3.11
50-Day Range
€2.44
▼
€3.27
52-Week Range
€5.06
▼
€21.69
Volume
942,631 shs
Average Volume
1.36 million shs
Market Capitalization
€550.33 million
P/E Ratio
N/A
Dividend Yield
2.63%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as autoimmune diseases, cancer, CNS diseases, diabetes, fibrosis, immunology, infectious diseases, kidney diseases, liver diseases, pain and inflammation, rare diseases, respiratory diseases, tuberculosis, and women's health. It has collaboration agreements with SK bioscience, JingXin, Carrick Therapeutics, Sernova, Topas Therapeutics, Exscientia, CONBA Group, Centrexion, Sanofi/NIH, Kazia Therapeutics, Bristol Myers Squibb, Topas Therapeutics, Immunitas, Exscientia, and Bayer, as well as a strategic partnership with Dewpoint Therapeutics to advance its portfolio targeting biomolecular condensates as a novel domain for therapeutic intervention towards the clinic. The company was formerly known as Evotec AG and changed its name to Evotec SE in April 2019. Evotec SE was incorporated in 1993 and is headquartered in Hamburg, Germany.

Receive EVT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Evotec and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

EVT Stock News Headlines

Did Evotec’s 60% Drop Catch You Out? What Investors Missed
Your free book is about to disappear
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.tc pixel
See More Headlines

EVT Stock Analysis - Frequently Asked Questions

Evotec's stock was trading at €5.45 at the beginning of the year. Since then, EVT shares have decreased by 45.6% and is now trading at €2.97.

Based on aggregate information from My MarketBeat watchlists, some other companies that Evotec investors own include Biogen (BIIB), Flux Power (FLUX), NIO (NIO), Evotec (EVTCY), Absci (ABSI), ACADIA Pharmaceuticals (ACAD) and Axcelis Technologies (ACLS).

Industry, Sector and Symbol

Stock Exchange
ETR
Industry
Life Sciences Tools & Services
Sub-Industry
Life Sciences Tools & Services
Current Symbol
ETR:EVT
CIK
N/A
Fax
N/A
Employees
5,061
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
(€0.92)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
0.98
Net Income
-€179.29 million
Net Margins
-25.16%
Pretax Margin
N/A
Return on Equity
-25.63%
Return on Assets
0.97%

Debt

Debt-to-Equity Ratio
65.02
Current Ratio
2.32
Quick Ratio
2.97

Sales & Book Value

Annual Sales
€717.62 million
Price / Sales
0.77
Cash Flow
€0.86 per share
Price / Cash Flow
3.45
Book Value
€3.61 per share
Price / Book
0.82

Miscellaneous

Outstanding Shares
185,544,981
Free Float
N/A
Market Cap
€550.33 million
Optionable
Not Optionable
Beta
1.27
The 7 Best High-Yield Dividend Stocks for 2027 Cover

Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.

Get This Free Report

This page (ETR:EVT) was last updated on 11/13/2026 by MarketBeat.com Staff.
From Our Partners